Clinical Trials Directory

Trials / Completed

CompletedNCT02953730

The Study on the Pharmacokinetics of PEG-rhG-CSF in Children and Adolescents

The Study on the Pharmacokinetics of Pegylated Recombinant Human Granulocyte Stimulating Factor(PEG-rhG-CSF) in Children and Adolescents

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
9 (actual)
Sponsor
Chinese Academy of Medical Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the trail is to study the pharmacokinetics of Pegylated Recombinant Human Granulocyte Stimulating Factor(PEG-rhG-CSF) in Children and Adolescents

Conditions

Interventions

TypeNameDescription
DRUGPEG-rhG-CSF

Timeline

Start date
2015-09-01
Primary completion
2016-06-01
First posted
2016-11-03
Last updated
2016-11-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02953730. Inclusion in this directory is not an endorsement.